Phase I-II Multicenter Study to Assess the Efficacy and Safety of the Chlorambucil + Lenalidomide Combination and Lenalidomide Maintenance Therapy in Untreated Elderly Pts With CLL. EudraCT Number 2009-013415-35.
Phase of Trial: Phase I/II
Latest Information Update: 27 Jan 2015
At a glance
- Drugs Chlorambucil (Primary) ; Lenalidomide (Primary)
- Indications Chronic lymphocytic leukaemia
- Focus Adverse reactions; Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 10 Jul 2012 Planned number of patients changed from 81 to 89 as reported by ClinicalTrials.gov.
- 07 Nov 2011 Actual initiation date Nov 2011 added as reported by ClinicalTrials.gov.